Number of the records: 1
digoxín
SYS d004077 LBL 00000nz--a2200000o--4500 005 20250606214157.4 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D04.210.500.155.580.130.500.436 065 $a D04.210.500.155.580.130.688 065 $a D09.408.180.261.436 066 $a 01 $c 03 150 $a digoxín $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000889 $Y Anti-Arrhythmia Agents $w P $a antiarytmiká 550 $7 sllk_us_auth*d002316 $Y Cardiotonic Agents $w P $a kardiotoniká 550 $7 sllk_us_auth*d004791 $Y Enzyme Inhibitors $w P $a inhibítory enzýmov 680 9-
$i A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) $2 eng 680 $a do not confuse with DIGITOXIN $2 eng 750 -2
$a Digoxin $2 eng 980 $x M
Number of the records: 1